|
| T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma |
|
https://doi.org/10.18632/oncotarget.27792
Christie P.M. Verkleij, Kristine A. Frerichs, Marloes Broekmans, Saida Absalah, Patricia W.C. Maas-Bosman, Sandy Kruyswijk, Inger S. Nijhof, Tuna Mutis, Sonja Zweegman, Niels W.C.J. van de Donk
|
| 4076-4081 |
|
| The impact of the RASSF1C and PIWIL1 on DNA methylation: the identification of GMIP as a tumor suppressor |
|
https://doi.org/10.18632/oncotarget.27795
Yousef G. Amaar, Mark E. Reeves
|
| 4082-4092 |
|
| Diffusion-weighted MR imaging histogram analysis in HIV positive and negative patients with primary central nervous system lymphoma as a predictor of outcome and tumor proliferation |
|
https://doi.org/10.18632/oncotarget.27800
Bilal Khan, Insun Chong, Quinn Ostrom, Sara Ahmed, Dima Dandachi, Aikaterini Kotrotsou, Rivka Colen, Fanny Morón
|
| 4093-4103 |
|
| Association between vitamin D and ovarian cancer development in BRCA1 mutation carriers |
|
https://doi.org/10.18632/oncotarget.27803
Tanja Pejovic, Sonali Joshi, Shawn Campbell, Sarah Thisted, Fuhua Xu, Jing Xu
|
| 4104-4114 |
|
| Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer |
|
https://doi.org/10.18632/oncotarget.27794
Chiara Nicolazzo, Flavia Loreni, Salvatore Caponnetto, Valentina Magri, Anna Rita Vestri, Rita Zamarchi, Angela Gradilone, Antonella Facchinetti, Elisabetta Rossi, Enrico Cortesi, Paola Gazzaniga
|
| 4115-4122 |
|
| Expression profiling on subclasses of primary parotid gland carcinomas |
|
https://doi.org/10.18632/oncotarget.27797
Jeannine Meinrath, Anja Haak, Nesrin Igci, Priya Dalvi, Christoph Arolt, Sonja Meemboor, Udo Siebolts, Hannah Eischeidt-Scholz, Claudia Wickenhauser, Inga Grünewald, Uta Drebber, Reinhard Büttner, Alexander Quaas, Jens-Peter Klußmann, Margarete Odenthal, Dirk Beutner, Moritz Meyer
|
| 4123-4137 |
|
| HIC1 (Hypermethylated in Cancer 1) modulates the contractile activity of prostate stromal fibroblasts and directly regulates CXCL12 expression |
|
https://doi.org/10.18632/oncotarget.27786
Marion Dubuissez, Sonia Paget, Souhila Abdelfettah, Nathalie Spruyt, Vanessa Dehennaut, Gaylor Boulay, Ingrid Loison, Clementine de Schutter, Brian R. Rood, Martine Duterque-Coquillaud, Xavier Leroy, Dominique Leprince
|
| 4138-4154 |
|
| CPEB1 orchestrates a fine-tuning of miR-145-5p tumor-suppressive activity on TWIST1 translation in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.27806
Fatemeh Rajabi, Win-Yan Liu-Bordes, Marina Pinskaya, Foretek Dominika, Gueorgui Kratassiouk, Guillaume Pinna, Simona Nanni, Antonella Farsetti, Christian Gespach, Arturo Londoño-Vallejo, Irina Groisman
|
| 4155-4168 |
|
| Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score |
|
https://doi.org/10.18632/oncotarget.27796
Noriyuki Hirahara, Takeshi Matsubara, Shunsuke Kaji, Yasunari Kawabata, Ryoji Hyakudomi, Tetsu Yamamoto, Yuki Uchida, Kazunari Ishitobi, Kiyoe Takai, Yoshitsugu Tajima
|
| 4169-4177 |
|
| AKT isoforms have discrete expression in triple negative breast cancers and roles in cisplatin sensitivity |
|
https://doi.org/10.18632/oncotarget.27746
Bhumika Wadhwa, Masroor Paddar, Sameer Khan, Sameer Mir, Philip A.Clarke, Anna M. Grabowska, Devanahalli G. Vijay, Fayaz Malik
|
| 4178-4194 |
|
| Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy |
|
https://doi.org/10.18632/oncotarget.27793
Rajnish Nagarkar, Darshana Patil, Sewanti Limaye, Pradip Devhare, Ashwini Ghaisas, Navin Srivastava, Sachin Apurwa, Sanket Patil, Jinumary John, Zarrine Raazi, Aditya Shreenivas, Janani Sambath, Ajay Srinivasan, Prashant Kumar, Dadasaheb Akolkar, Rajan Datar
|
| 4195-4200 |
